News by region

  • How engineering simulation technology is revolutionising cardiovascular research

    By Thierry Marchal, programme director and chief technologist (EMEA healthcare), at Ansys Cardiovascular disease remains the world's leading killer, claiming nearly a third of all global deaths according to the World Health Organisation. While traditional research methods have made significant strides, we are now entering an era where understanding the complex mechanics of the human [...]

  • health.tech returns with bold new vision through joint venture between MCH Group and Bits & Pretzels

    MCH Group, the Swiss-based global experience marketing leader, and Bits & Pretzels, Europe’s premier founder platform, today announced a strategic joint venture to relaunch the health.tech event on 3-5 March 2026.  The event, to be held in Basel, Switzerland, will bring together the most influential voices across the European and UK healthcare value chain—startups, scale-ups, [...]

  • COMMENT: Global tariffs will accelerate AI adoption in healthcare

    By Mika Newton, CEO of xCures Global tariffs, particularly those focused on China, are creating unique pressures on the US healthcare system that will accelerate the adoption of AI automation to cut costs. Here’s why: First – US medical supply chains are intimately tied to China and it will take years to adjust those back to [...]

  • Optellum announces agreement with Bristol Myers Squibb to leverage AI to boost early lung cancer diagnosis

    Optellum, a global leader in AI-driven clinical decision support for early lung cancer diagnosis, has entered an agreement with Bristol Myers Squibb (NYSE: BMY), to leverage AI in early diagnosis and precision lung cancer care. Under the agreement, Optellum will apply its AI-powered imaging & clinical decision support platform to evaluate the real-world impact on [...]

  • COMMENT: How mobile scanning could prevent thousands of medication errors annually

    By Max Stratmann, CRO of scanning tech firm Scanbot SDK Medication errors are a persistent danger to patient safety, with the FDA receiving over 100,000 error reports annually. The United States alone spends more than $40 billion each year addressing these medical errors. The need for innovative solutions is, therefore, urgent.   The [...]

  • Your weekly health tech deals digest

    We round up the big deals, investment and partnerships news from the past week AMBOSS closes €240m financing round  AMBOSS, the resource for medical education and clinical decision-making in Germany and the US, has closed a €240m financing round with new long-term investors.   The round supports the exploration of additional international markets [...]

  • How AI changes the way we treat mental disorders

    By Igor Dolgushin, Doctor of Medicine, CEO and Founder of SENSOR23 At SENSOR23, we believe that a clear and healthy mind is the foundation of a happy life. Our mission is simple: to help people manage their mental health and truly feel their best every day. We work with a wide range of conditions—anxiety, depression, [...]

  • Final stands available for UK health tech at WHX Miami 2025

    UK HealthTech companies looking to expand into the Americas have a final opportunity to join the Association of British HealthTech Industries (ABHI) at WHX Miami (formerly FIME), the largest international medical trade event in the Americas, taking place from 11-13 June. As the healthcare landscape in the Americas continues to evolve, the demand for innovative [...]

  • Advanced genetic blueprint could unlock precision medicine

    Creation of a genetic representation for more than 2.5 billion people across the Middle East and South Asia could make a major contribution towards advancing precision medicine. Traditional genetic research has mainly relied on linear reference genomes, which is like having a single, standard version of human DNA that scientists compare everyone's genetic information against. [...]

  • Heart condition treatment pioneer Pulnovo bolstered by fundraise

    Pulnovo Medical, which is developing minimally invasive treatments for pulmonary hypertension and heart failure, has raised almost US$100m to drive its growth. The medtech firm’s flagship product is PADN (pulmonary artery denervation) technology; a minimally invasive treatment for pulmonary hypertension (PH) PH is a condition that can lead to heart failure and mortality, with limited [...]